SOTA 06: Living Donor Liver Transplantation
Chung Mau Lo
Professor Chung-Mau Lo graduated from the Faculty of Medicine of the University of Hong Kong and received surgical training at Queen Mary Hospital. He was appointed as an Associate Professor at the University of Hong Kong in 1996 and was promoted to Professor of Surgery in 1999. He became a Chair Professor in 2004 and is currently Chin Lan Hong Professor and Chief of Divisions of Hepatobiliary/Pancreatic Surgery and Liver Transplantation. He is internationally renowned for his excellence in hepatobiliary surgery, particularly in his pioneering work in living donor liver transplant. His research interests are focused in hepatobiliary surgery and liver transplantation and he has published over 240 original articles in refereed international journals. He is currently the President and a Council Member of the International Liver Transplantation Society and the Past-President of the International Society for Digestive Surgery.
Abraham Shaked
Dr. Shaked holds an M.D. degree from the Hebrew University and Hadassah medical school in Jerusalem and a Ph.D. in Molecular Pathology and Immunology from the City University of New York. He went through residency training in General Surgery at the Mount-Sinai Hospital in NYC and subsequently did a fellowship and served as a faculty in Transplantation Surgery at UCLA.
Dr. Shaked currently serves as the Director of the Penn Transplant Institute, and Chief of the Division of Transplantation at the University of Pennsylvania. He is the holder of the Eldridge L. Eliason Chair in Surgery. His surgical practice has focused on the liver transplantation.
Dr. Shaked served as the program chair, the secretary, and the President of the American Society of Transplant Surgeons. His national activities include membership of board of Directors of UNOS, participation in multiple NIH committees, and appearances in various congressional committees.Dr. Shaked research interests are focused on transplant immunobiology in the human setting. Current project include: 1. The use of gene expression profiling for the characterization of the interrelation between proinflammatory response innate immunity and adaptive immunity pertinent to solid organ transplantation. 2. The interrelations between tolerance alloimmune response, anti- hepatitis C response, and immunosuppression in liver transplant recipients. 3. Pattern and mechanisms of immune response in the regenerating liver of recipients undergoing living donor liver transplantation. Dr. Shaked’s research is funded by the National Institute of Health (NIH) and Immune Tolerance Network. He has published more than 170 original articles, and is serving on editorial board of various transplantation and surgical journals.
David R. Grant, MD, FRCSC
Dr. Grant obtained his medical and surgical training at the University of Western Ontario. He was on staff at the London Health Sciences Centre until 1999, when he moved to Toronto. Research interests include: tolerance, small-bowel transplantation, living donor liver transplantation, and xenotransplantation. Dr. Grant performed the first liver-small bowel transplant in 1989, and he is the Director of the International Intestine Transplant Registry. Dr. Grant has published more than 200 papers and book chapters.
He serves on the editorial boards of Transplantation, Transplantation Proceedings, and Transplant International.